CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Open-market sale Chief Financial Officer sold 6,476 shares at $4.24 ($27,458)
- 4 Open-market sale General Counsel sold 6,181 shares at $4.24 ($26,207)
- 4 Open-market sale President and CEO sold 19,669 shares at $4.24 ($83,397)
- 4 Grant or award Chief Business Officer acquired 44,444 shares (grant or award)
- 4 Grant or award General Counsel acquired 55,556 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 55,556 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 55,556 shares (grant or award)
- 4 Grant or award President and CEO acquired 176,300 shares (grant or award)
- 4 Open-market buy 10% owner bought 7,328 shares at $3.50 ($25,648)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 20,000 shares at an average $3.95 ($78,975)
- 4 Open-market buy 10% owner bought 150,000 shares at an average $4.59 ($689,230)
- 4 Grant or award Chief Medical Officer acquired 6,667 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 8,933 shares (grant or award)
- 4 Grant or award Director acquired 8,933 shares (grant or award)
- 4 Grant or award Director acquired 8,933 shares (grant or award)
- 4 Grant or award Director acquired 8,933 shares (grant or award)
- 4 Grant or award Director acquired 8,933 shares (grant or award)
Page 8 of 18 · 354 filings